Our highly qualified scientists provide insight into the latest biomarkers, assays and testing approaches and develop innovative solutions for unique challenges across all research phases, to pharmaceutical, biotechnology, medical device, government, public health, and CRO organizations.
Cerba Research’s extensive capability in laboratory testing and global logistics including Bioanalysis, Flow Cytometry, HistoCytopathology, and Next-Generation Sequencing, enables us to drive operational agility at scale in a wide range of therapeutic areas, with recognized expertise in Virology, Immunology, Oncology and Cell & Gene Therapy.
Cerba Research is part of the Cerba HealthCare Group with 15,000 employees on five continents, driven to advance diagnosis and health.
For more information about Cerba Research, please visit cerbaresearch.com.
